Beijing and Shanghai – November 22, 2023 – The Legal 500 Asia Pacific has recognized Cooley practices across China, highlighting the firm's investment funds, life sciences and healthcare, and private equity teams as top practice groups.
Partner Christina Zhang was recommended as a Leading Individual, while partner Jingyi Xu was highlighted as a Next Generation Partner. In addition, partner Ruomu Li was recognized as a Leading Individual and a Next Generation Partner in several practice areas.
The following Cooley practices and lawyers were ranked in The Legal 500 Asia Pacific 2024 guide:
Leading Practice Groups
Investment Funds: Foreign Firms – China
Life Sciences and Healthcare: Foreign Firms – China
Private Equity: Foreign Firms – China
Leading Individuals
Ruomu Li – Corporate and M&A, China
Christina Zhang – Life Sciences and Healthcare, China
Next Generation Partner
Ruomu Li – Life Sciences and Healthcare, China; Private
Equity, China
Jingyi Xu – Investment Funds, China
Key Lawyers – Investment Funds: Foreign
Firms
Pang Lee, China
Jordan Silber, China
Xun Zeng, China
Key Lawyers – Life Sciences and Healthcare:
Foreign Firms – China
Ruomu Li
Yiming Liu
Patrick Loofbourrow
Christina Zhang
Key Lawyers – Private Equity: Foreign Firms
– China
Ruomu Li
Yiming Liu
Patrick Loofbourrow
Christina Zhang
Lunga Su
Cooley represents a growing number of Asia's most innovative and dynamic tech and life sciences companies, advising at all stages of the business life cycle, from formation through financings and exits. Among all international law firms practicing in Asia, Cooley has one of the largest offshore fund formation teams resident in mainland China, offering the deepest experience and greatest reach and depth for China venture capital fund formation – especially for VC firms focused on early and growth stages.
In addition, Cooley's Asia team has in-depth subject matter knowledge and transactional prowess, enabling the firm to handle a raft of corporate, finance, licensing, M&A, and capital markets work for international and Asia-based life sciences and technology entities engaged in inbound and outbound services. The team's in-depth subject matter knowledge and transactional prowess enable the firm to handle a raft of corporate, finance, licensing, M&A, and capital markets work for international and Asia-based life sciences and technology entities engaged in inbound and outbound services.